Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

待确认 10 由星发布于 2026/3/14 23:22:12

DOI:10.1161/hypertensionaha.125.25739
作者：Tsukasa Iwakura,Kengo Kidokoro,Rie Tatsugawa,Akira Hirano,Eriko Kajimoto,Masanobu Takasu,Masafumi Wada,Yoshihisa Wada,Hiroyuki Kadoya,Seiji Kishi,Hajime Nagasu,David Z I Cherney,Tamaki Sasaki,Naoki Ka
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1161/hypertensionaha.125.25739

Wolters Kluwer Ovid

Abstract：BACKGROUND Recent studies have confirmed the protective effects of nonsteroidal MR (mineralocorticoid receptor) antagonists in diabetic kidney disease. However, the physiological mechanisms

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

3小时前

性感辣妹子长年在线

5306fe661ffc11f1a1ca34735aa3bc31.pdf

11小时前

Book学术机器人

2026/3/14 23:22:12 未找到该文献，机器人已退出，请等待人工下载

2026/3/14 23:22:12 Book学术AI机器人收到请求，开始寻找文献

2026/3/14 23:22:12 已向机器人发送请求

11小时前

星发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Acarbose ameliorates podocyte injury and glomerular lesions in diabetic nephropathy through USP46 activation.